- Joined
- Aug 23, 2014
- Messages
- 3,353
- Reaction score
- 6,877
That pic of Ron D with the proton grift mafia really is quite something folks! im loving the guy rocking the seersucker!
Isn't this argument true with any neoadjuvant treatment (i.e. sarcoma, rectal)?Did not include nodes in this study.
![]()
Phase 1 trial of neoadjuvant radiation therapy before prostatectomy for high-risk prostate cancer - PubMed
Neoadjuvant RT is feasible with moderate urinary morbidity. However, oncologic outcomes do not seem to be substantially different from those with selective postoperative RT. If this multimodal approach is further evaluated in a phase 2 setting, 54 Gy should be used in combination with...pubmed.ncbi.nlm.nih.gov
Bigger issue is that no one wants to do preop (because is screws you on the backend if salvage XRT is needed)
That pic of Ron D with the proton grift mafia really is quite something folks! im loving the guy rocking the seersucker!
It sure looks like some of those guys are eating quite well! You know what i mean?NY Proton center will rob you blind and then ask you to let them proton you to give half your money back.
it's quite the grift.
When I was looking 10+ yrs ago, thier offers were low, even for SoCal. I am unsure if that has changed.Great place.... If you're a med onc
Immunotherapy works SUPER well in many trials, like, 10-20% of the time 🙂
whats lowWhen I was looking 10+ yrs ago, thier offers were low, even for SoCal. I am unsure if that has changed.
You know, I was on a virtual ASCO review and a medical oncologist speaker made a declarative statement that the 5 year survival for stage III lung cancer is 20% in the context of neoadjuvant chemoimmunotherapy and none of the medical oncologists bothered to corrected the speaker or reference the PACIFIC trial. I wonder if that is why they are "winning" and we are "losing".That is not completely accurate. 5-year OS in metastatic melanona is now 50% compared to 5% (?) about 20 years ago. It comes with a price though, combining Ipi+Nivo will cause Grade 3 toxicity in something like 60% of patients.
The role of neoadjuvant therapy varies by site, right? Based on the design of prior trials.Isn't this argument true with any neoadjuvant treatment (i.e. sarcoma, rectal)?
Is it possible neoadjvuant RT would mitigate the need for salvage with prostate? (honestly asking)
Isn't this argument true with any neoadjuvant treatment (i.e. sarcoma, rectal)?
Is it possible neoadjvuant RT would mitigate the need for salvage with prostate? (honestly asking)
what about a randomized trial of ADT/RT versus surgery?The role of neoadjuvant therapy varies by site, right? Based on the design of prior trials.
The argument for neoadjuvant therapy for sarcoma is reducing the risk of late toxicity.
With rectal, it's acute and late toxicity benefit and the opportunity for TNT if you are in to that sort of thing.
In this trial, it seemed like the reason was because 1) surgeons can't resist operating on higher risk patients, 2) its hard to clean up the mess after surgery and/or 3) people aren't referred for adjuvant. Creative solution to a funny problem. Since it didn't work, what about a randomized trial of ADT/RT versus surgery? 🤣
(To be clear, I liked the cited phase 1 trial, good stuff)
Hopefully this results in time to inform my decision on treating my own prostate cancer.
You know, I was on a virtual ASCO review and a medical oncologist speaker made a declarative statement that the 5 year survival for stage III lung cancer is 20% in the context of neoadjuvant chemoimmunotherapy and none of the medical oncologists bothered to corrected the speaker or reference the PACIFIC trial. I wonder if that is why they are "winning" and we are "losing".
So to fight fire with fire, yes, immunotherapy is usually expensive trash.
For the 80 to 90% treated with immunotherapy with no benefit with immunotherapy (whether in the definitive or adjuvant settings), yes it is trash without price regulation.Trash?
Dude what
Not sure how you think that only ten - twenty percent of patients derive benefit. For example the only subset that derives no benefit in PACIFIC is PDL1 0%For the 80 to 90% treated with immunotherapy with no benefit with immunotherapy (whether in the definitive or adjuvant settings), yes it is trash without price regulation.
Estimated enrollment of 1200?Hopefully this results in time to inform my decision on treating my own prostate cancer.
These getting randomized to radiation vs surgery trials rarely work out. I was looking to see how many have enrolled but didn't look hard.Estimated enrollment of 1200?
That seems . . . optimistic
Could never pull it off in the US. I'd be interested to know more about how they offer this trial in the environment of socialized medicine.Estimated enrollment of 1200?
That seems . . . optimistic
I did email the PI inquiring about accrual. I will let you know if I hear anythingEstimated enrollment of 1200?
That seems . . . optimistic
The role of neoadjuvant therapy varies by site, right? Based on the design of prior trials.
The argument for neoadjuvant therapy for sarcoma is reducing the risk of late toxicity.
With rectal, it's acute and late toxicity benefit and the opportunity for TNT if you are in to that sort of thing.
In this trial, it seemed like the reason was because 1) surgeons can't resist operating on higher risk patients, 2) its hard to clean up the mess after surgery and/or 3) people aren't referred for adjuvant. Creative solution to a funny problem. Since it didn't work, what about a randomized trial of ADT/RT versus surgery? 🤣
(To be clear, I liked the cited phase 1 trial, good stuff)
Not worth my time to engage with the ad hominem king of probation but strictly for educational purposes:Not sure how you think that only ten - twenty percent of patients derive benefit. For example the only subset that derives no benefit in PACIFIC is PDL1 0%
But anyways it’s clearly not trash in the metastatic setting either.
Super weird take.
People are quite feisty today. I think it’s the heat.Not worth my time to engage with the ad hominem king of probation but strictly for educational purposes:
![]()
Eligibility for and Response to Checkpoint Inhibitor Immunotherapy Drugs for Cancer
This cross-sectional study estimates the percentage of US patients with cancer who were eligible for and who responded to checkpoint inhibitor immunotherapy drugs between 2011 and 2018.jamanetwork.com
Also, have a look at the survival curves of the Pacific trial +/- immunotherapy.
If you would like to cheerlead for Big Pharma, might I suggest the Medical Oncology or Psychiatry forums.
See you at the other side of probation my friend!
I blame the economy.People are quite feisty today. I think it’s the heat.
Doing fine for everyone around me except me #radoncI blame the economy.
Tell that to my portfolio!Doing fine for everyone around me except me #radonc
![]()
U.S. labor market powers ahead with strong job gains despite recession fears
Employers hired far more workers than expected in June and continued to raise wages at a steady clip.www.reuters.com
Main street is doing better than wall street ... Landlords and real estate tycoons are crushing it this yearTell that to my portfolio!
Landlords and real estate tycoons are crushing it this year
Repos are up. Housing market is slowing. We're going from a period of free money, low supply, and high demand to the exact opposite. Winter is coming!Yeah. That party is going to stop real soon, and it will spectacular when all this blows up.
Have some cash on hand. Will be some great deals for patient value investors in all sectors.
Those addicted to spending and debt are going to be in for a world of pain.
When Americans, of all people, are skipping meals and eating smaller portions, you know we are getting into a really bad situation. Talk about a canary in the coal mine.Repos are up. Housing market is slowing. We're going from a period of free money, low supply, and high demand to the exact opposite. Winter is coming!
When Americans, of all people, are skipping meals and eating smaller portions, you know we are getting into a really bad situation. Talk about a canary in the coal mine.
We might have a big problem here -- We can't have everybody else coming and crowding up the breadlines. Those are for rad onc!!!Might reduce the national BMI if it goes on longer. Silver lining.
We might have a big problem here -- We can't have everybody else coming and crowding up the breadlines. Those are for rad onc!!!
Can we at least get the chocolate covered grasshoppers on doctors day?No we are in the artificial meat scrap line. Non inferiority trial just Published in the UK between bread and meat scraps pulled off the floor of the slaughter house and fortified with vitamins…enjoy
Repos are up. Housing market is slowing. We're going from a period of free money, low supply, and high demand to the exact opposite. Winter is coming!
Not happening... Unfortunately we've been underbuilding since 2009, despite sales falling this summer, median housing price is still going up and at an all time high.Repos are up. Housing market is slowing. We're going from a period of free money, low supply, and high demand to the exact opposite. Winter is coming!
Not happening... Unfortunately we've been underbuilding since 2009, despite sales falling this summer, median housing price is still going up and at an all time high.
I would say housing inflation is our biggest problem by far (more than food, gas etc). It's no surprise that PE and companies backed by bezos are getting into the landlord game lately.
![]()
U.S. existing home sales slide again; prices hit fresh record high
Fast-rising rates and record-high selling prices are making buying a home too expensive for a growing share of American households.www.reuters.com
Russians and Chinese treat NYC, Toronto, Vancouver, heck even Miami condos as nice cash equivalents esp in a strong dollar climate like we are in nowand foreign investors
Not happening... Unfortunately we've been underbuilding since 2009, despite sales falling this summer, median housing price is still going up and at an all time high.
I would say housing inflation is our biggest problem by far (more than food, gas etc). It's no surprise that PE and a company backed by bezos are getting into the landlord game lately.
![]()
U.S. existing home sales slide again; prices hit fresh record high
Fast-rising rates and record-high selling prices are making buying a home too expensive for a growing share of American households.www.reuters.com
That's what caused the first bubble 2005-2007. Homebuilders and banks obviously got hosed and have been underbuilding ever since esp at the low end/first time sector of the marketThere is some compelling arguments that most of housing inflation is due to falling interest rates since the 1990s. I can’t find the original article I read showing this but see this one making the case.
About time. Basic houses in my neck of the woods are up to 2.5 million. That's for something nice and tiny or relatively big and fixer upper. I thought things were out of control when I was saying that they were 1.5 million two years ago. Who can afford this?
How bout you guys lobby for better than 1.96 wrvu?Are radiation oncologists conspicuously absent from this press release because they're absent from radiopharmaceutical therapy in real life? I don't like.
Related:
Unsealed Source: Scope of Practice for Radiopharmaceuticals Among United States Radiation Oncologists
Radoncs are very much absent in real life in large academic systems, maybe with the exception of 1 or 2 centers. Neither unsealed sources or FLASH will save the field.Are radiation oncologists conspicuously absent from this press release because they're absent from radiopharmaceutical therapy in real life? I don't like.
Related:
Unsealed Source: Scope of Practice for Radiopharmaceuticals Among United States Radiation Oncologists
Radoncs are very much absent in real life in large academic systems, maybe with the exception of 1 or 2 centers. Neither unsealed sources or FLASH will save the field.